Small molecule PROTACs in targeted therapy: An emerging strategy to induce protein degradation-Reference-Cited by-同舟云学术

Small molecule PROTACs in targeted therapy: An emerging strategy to induce protein degradation

Published:2019-07 Issue: Volume:174 Page:159-180
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Xi Meiyang,Chen Yi,Yang Hongyu,Xu Huiting,Du Kui,Wu Chunlei,Xu Yanfei,Deng Liping,Luo Xiang,Yu Lemao,Wu Yonghua,Gao Xiaozhong,Cai Tao,Chen Bin,Shen Runpu,Sun Haopeng^ORCID

Funder

Science Foundation of Shaoxing University

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference127 articles.

1. Large-Scale profiling of kinase dependencies in cancer cell lines;Campbell;Cell Rep.,2016

2. Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies;Cowley;Sci. Data.,2014

3. Monoclonal antibodies as immunomodulatory therapy against cancer and autoimmune diseases;Hafeez;Curr. Opin. Pharmacol.,2018

4. The history of monoclonal antibody development - progress, remaining challenges and future innovations;Liu;Ann. Med. Surg.,2014

5. Privileged structures: efficient chemical “navigators” toward unexplored biologically relevant chemical spaces;Kim;J. Am. Chem. Soc.,2014

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody-drug conjugates for targeted cancer therapy: Recent advances in potential payloads;European Journal of Medicinal Chemistry;2024-10

2. PROTAC: Novel degradable approach for different targets to treat breast cancer;European Journal of Pharmaceutical Sciences;2024-07

3. Therapeutic expression of RAS Degrader RRSP in Pancreatic Cancer via Nanocarrier-mediated mRNA delivery;2024-06-14

4. Selective degradation of hyperphosphorylated tau by proteolysis-targeting chimeras ameliorates cognitive function in Alzheimer’s disease model mice;Frontiers in Pharmacology;2024-06-11

5. EGFR degraders in non‐small‐cell lung cancer: Breakthrough and unresolved issue;Chemical Biology & Drug Design;2024-04